Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists
Figure 6
Synthesis of target piperazine derivatives 23a–h.
Reagents and conditions: a) SOCl2, EtOH, 0°C, 0.5 h, rt, 3 h, reflux, 1 h; b) (Boc)2O, NaOH, H2O, Dioxane, rt, 12 h; c) DIBAL-H, CH2Cl2, −78°C, 3 h; d) NaBH(OAc)3, CH2Cl2, rt, 8 h; e) 6NHCl, EtOAc, rt, 3 h; f) EDC.HCl, CH2Cl2, rt, 6 h.